| 000 | 01681 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515015206.0 | ||
| 264 | 0 | _c20060310 | |
| 008 | 200603s 0 0 ita d | ||
| 022 | _a1129-471X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 245 | 0 | 0 |
_a[Workshop II--Clinical and therapeutic pathways]. _h[electronic resource] |
| 260 |
_bItalian heart journal : official journal of the Italian Federation of Cardiology _cNov 2005 |
||
| 300 |
_a12S-26S p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAbciximab |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAngioplasty, Balloon, Coronary |
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Protocols |
| 650 | 0 | 4 | _aConfidence Intervals |
| 650 | 0 | 4 | _aElectrocardiography |
| 650 | 0 | 4 | _aEmergency Medical Services |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aHeart Failure _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Fab Fragments _xadministration & dosage |
| 650 | 0 | 4 | _aItaly |
| 650 | 0 | 4 | _aMeta-Analysis as Topic |
| 650 | 0 | 4 |
_aMyocardial Infarction _xcomplications |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 |
_aPlatelet Glycoprotein GPIIb-IIIa Complex _xantagonists & inhibitors |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 |
_aShock, Cardiogenic _xetiology |
| 650 | 0 | 4 | _aThrombolytic Therapy |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 773 | 0 |
_tItalian heart journal : official journal of the Italian Federation of Cardiology _gvol. 6 Suppl 6 _gp. 12S-26S |
|
| 999 |
_c16103060 _d16103060 |
||